國立虎尾科技大學 |

Investigating the Role of Cellular Senescence in Skeletal Muscle and Sarcopenia.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Investigating the Role of Cellular Senescence in Skeletal Muscle and Sarcopenia./
Author:	Shigdar, Shahjahan Miah.
Description:	1 online resource (301 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 83-06, Section: B.
Contained By:	Dissertations Abstracts International83-06B.
Subject:	Adenosine. -
Online resource:	click for full text (PQDT)
ISBN:	9798759927310

Investigating the Role of Cellular Senescence in Skeletal Muscle and Sarcopenia.
Shigdar, Shahjahan Miah.

Investigating the Role of Cellular Senescence in Skeletal Muscle and Sarcopenia. - 1 online resource (301 pages)

Source: Dissertations Abstracts International, Volume: 83-06, Section: B.

Thesis (Ph.D.)--The University of Liverpool (United Kingdom), 2021.

Includes bibliographical references

Senescence was first described by the pioneering work of Hayflick whereby human diploid fibroblasts underwent repeated population doublings, and the cells demonstrated a finite replicative limit in culture. It is now recognised that most replicative cells have the capability to undergo senescence. More recently senescence-like properties have been described in terminally differentiated cells, including skeletal muscle, although the nature of this senescence remains unclear. There is limited data examining the role of senescence in the determination of terminally differentiated tissues such as skeletal muscle.The overall hypothesis of this thesis was that senescent cells accumulate in old mice, either locally to skeletal muscle or distally, and that they produce an inflammatory Senescence Associated Secretory Phenotype (SASP) which may contribute at least in part to the chronic NF-κB activation and the loss of muscle mass and function seen in the muscles of old compared with adult wild type (WT) mice. This programme of work tested this hypothesis by utilising different models of senescence in vitro and in vivo and using a senolytic and transgenic intervention.Initial studies examined the potential for mouse skeletal muscle myoblasts (C2C12 myoblasts) to undergo senescence when treated with the DNA damaging agent, etoposide. Treatment of cells with etoposide resulted in cell cycle arrest, increased levels of p21, increased SA-β-Gal activity, and altered morphology, providing proof-of-principle that mononuclear myoblasts can become senescent. Further, the senescent myoblasts produced a proinflammatory SASP detectable in the cell media that was able to increase NF-κB transcription factor activity in mature C2C21 myotubes. Interpretation and comparison of data from senescent cells and control cells proved a challenge since under normal conditions, control myoblasts continue to divide until reaching confluence and contact inhibition occurs. At this point muscle cells initiate differentiation, with expression of some indices common to senescence.Examination of muscles of old WT mice showed no evidence of the presence of classical senescent cells in muscles of old mice although old mice showed evidence of increased levels of cytokines and chemokines in the plasma. Data suggest that muscle may partially contribute to the increase in some of these plasma cytokines/chemokines by a non-senescent mechanism. In support of this conclusion, studies using either a transgenic or a pharmacological approach to remove whole body senescent cells in old mice had some minor effects on plasma cytokine/chemokine levels but provided no protection against the age-related loss of muscle mass and function.Evidence for the presence of senescence cells in old mice remains unclear but some studies have suggested that removal of senescent cells provides protection against age-related muscle loss. One potential reason for the difference with the current study is the age of the mice used whereby studies that have demonstrated senescence within skeletal muscle have commonly made use of geriatric (32-months-old) mice suggesting that senescence is only involved in the very late stages of sarcopenia.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798759927310Subjects--Topical Terms:

788963
Adenosine.
Index Terms--Genre/Form:

554714
Electronic books.

Investigating the Role of Cellular Senescence in Skeletal Muscle and Sarcopenia.
LDR:04747ntm a22004697 4500 001 1149465
005 20241022112104.5
006 m o d
007 cr bn ---uuuuu
008 250605s2021 xx obm 000 0 eng d
020 $a 9798759927310
035 $a (MiAaPQ)AAI28871421
035 $a (MiAaPQ)Liverpool_3134929
035 $a AAI28871421
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Shigdar, Shahjahan Miah. $3 1475718
245 1 0 $a Investigating the Role of Cellular Senescence in Skeletal Muscle and Sarcopenia.
264 0 $c 2021
300 $a 1 online resource (301 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 83-06, Section: B.
500 $a Advisor: McArdle, Anne;Vasilaki, Aphordite;Staunton, Caroline.
502 $a Thesis (Ph.D.)--The University of Liverpool (United Kingdom), 2021.
504 $a Includes bibliographical references
520 $a Senescence was first described by the pioneering work of Hayflick whereby human diploid fibroblasts underwent repeated population doublings, and the cells demonstrated a finite replicative limit in culture. It is now recognised that most replicative cells have the capability to undergo senescence. More recently senescence-like properties have been described in terminally differentiated cells, including skeletal muscle, although the nature of this senescence remains unclear. There is limited data examining the role of senescence in the determination of terminally differentiated tissues such as skeletal muscle.The overall hypothesis of this thesis was that senescent cells accumulate in old mice, either locally to skeletal muscle or distally, and that they produce an inflammatory Senescence Associated Secretory Phenotype (SASP) which may contribute at least in part to the chronic NF-κB activation and the loss of muscle mass and function seen in the muscles of old compared with adult wild type (WT) mice. This programme of work tested this hypothesis by utilising different models of senescence in vitro and in vivo and using a senolytic and transgenic intervention.Initial studies examined the potential for mouse skeletal muscle myoblasts (C2C12 myoblasts) to undergo senescence when treated with the DNA damaging agent, etoposide. Treatment of cells with etoposide resulted in cell cycle arrest, increased levels of p21, increased SA-β-Gal activity, and altered morphology, providing proof-of-principle that mononuclear myoblasts can become senescent. Further, the senescent myoblasts produced a proinflammatory SASP detectable in the cell media that was able to increase NF-κB transcription factor activity in mature C2C21 myotubes. Interpretation and comparison of data from senescent cells and control cells proved a challenge since under normal conditions, control myoblasts continue to divide until reaching confluence and contact inhibition occurs. At this point muscle cells initiate differentiation, with expression of some indices common to senescence.Examination of muscles of old WT mice showed no evidence of the presence of classical senescent cells in muscles of old mice although old mice showed evidence of increased levels of cytokines and chemokines in the plasma. Data suggest that muscle may partially contribute to the increase in some of these plasma cytokines/chemokines by a non-senescent mechanism. In support of this conclusion, studies using either a transgenic or a pharmacological approach to remove whole body senescent cells in old mice had some minor effects on plasma cytokine/chemokine levels but provided no protection against the age-related loss of muscle mass and function.Evidence for the presence of senescence cells in old mice remains unclear but some studies have suggested that removal of senescent cells provides protection against age-related muscle loss. One potential reason for the difference with the current study is the age of the mice used whereby studies that have demonstrated senescence within skeletal muscle have commonly made use of geriatric (32-months-old) mice suggesting that senescence is only involved in the very late stages of sarcopenia.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Adenosine. $3 788963
650 4 $a Ontology. $3 559386
650 4 $a Cancer therapies. $3 1468563
650 4 $a DNA damage. $3 582916
650 4 $a Cytokines. $3 581465
650 4 $a Chronic illnesses. $3 1437672
650 4 $a Biology. $3 599573
650 4 $a Epigenetics. $3 884396
650 4 $a Polymerase chain reaction. $3 590496
650 4 $a Genotype & phenotype. $3 1372654
650 4 $a Genes. $3 600074
650 4 $a Apoptosis. $3 581343
650 4 $a Kinases. $3 1473584
650 4 $a Cell cycle. $3 787710
650 4 $a Cell culture. $3 583545
650 4 $a Musculoskeletal system. $3 595675
650 4 $a Aging. $3 559847
650 4 $a Cyclin-dependent kinases. $3 683817
650 4 $a Genetic engineering. $3 592227
650 4 $a Chromosomes. $3 582176
650 4 $a Phosphorylation. $3 1467389
650 4 $a Morphology. $3 1183868
650 4 $a Biochemistry. $3 582831
650 4 $a Bioengineering. $3 598252
650 4 $a Cellular biology. $3 1148666
650 4 $a Chemistry. $3 593913
650 4 $a Engineering. $3 561152
650 4 $a Genetics. $3 578972
650 4 $a Gerontology. $3 559846
650 4 $a Immunology. $3 592892
650 4 $a Medicine. $3 644133
650 4 $a Philosophy. $3 559771
655 7 $a Electronic books. $2 local $3 554714
690 $a 0493
690 $a 0306
690 $a 0287
690 $a 0487
690 $a 0202
690 $a 0379
690 $a 0485
690 $a 0537
690 $a 0369
690 $a 0351
690 $a 0982
690 $a 0564
690 $a 0422
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a The University of Liverpool (United Kingdom). $3 1335391
773 0 $t Dissertations Abstracts International $g 83-06B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28871421 $z click for full text (PQDT)